close

EFPIA-DIA OPPI Regulatory Workshop New Delhi, India

Participants will have the opportunity to interact with regulators including WHO, DCG(I), Indian MoH and Members of European Federation of Pharmaceutical Industries and Associations (EFPIA India Regulatory Network) and the Organisation of Pharmaceutical Producers of India (OPPI) on key regulatory topics including Orphan drug regulation, Clinical trial waiver, Accelerated regulatory pathway and Biological product/ Biosimilars registration in India.